| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.086 | 0.1 |